Menu

Prothena Corporation plc PRTA

Full chart Compare
Set alert

Price alert · PRTA

All alert types
8.73 USD +0.17 (+1.99%)

At closeNov 11, 2026, 4:01 PM EST

8.73 0.00 0.00%

After hours · Nov 11, 4:01 PM ET

8.48 Day range 8.78
7.73 52-week range 11.80
YTD
-8.59%
1 year
-16.70%

PRTA revenue history

Revenue is income from the company’s ordinary business activities.

9,684,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2009: 2,500,000USDFY 2010: 1,243,000USDFY 2011: 507,000USDFY 2012: 2,658,000USDFY 2013: 676,000USDFY 2014: 50,854,000USDFY 2015: 1,607,000USDFY 2016: 1,055,000USDFY 2017: 27,519,000USDFY 2018: 955,000USDFY 2019: 814,000USDFY 2020: 853,000USDFY 2021: 200,577,000USDFY 2022: 53,905,000USDFY 2023: 91,370,000USDFY 2024: 135,157,000USDFY 2025: 9,684,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-319,684,000-125,473,000-92.83%
FY 20242024-12-31135,157,00043,787,00047.92%
FY 20232023-12-3191,370,00037,465,00069.50%
FY 20222022-12-3153,905,000-146,672,000-73.13%
FY 20212021-12-31200,577,000199,724,00023414.30%
FY 20202020-12-31853,00039,0004.79%
FY 20192019-12-31814,000-141,000-14.76%
FY 20182018-12-31955,000-26,564,000-96.53%
FY 20172017-12-3127,519,00026,464,0002508.44%
FY 20162016-12-311,055,000-552,000-34.35%
FY 20152015-12-311,607,000-49,247,000-96.84%
FY 20142014-12-3150,854,00050,178,0007422.78%
FY 20132013-12-31676,000-1,982,000-74.57%
FY 20122012-12-312,658,0002,151,000424.26%
FY 20112011-12-31507,000-736,000-59.21%
FY 20102010-12-311,243,000-1,257,000-50.28%
FY 20092009-12-312,500,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-09T07:00:38.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.